Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,319,669
+$700,834 QoQ
Shares Held
21,140
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#1,271
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. ABBV ranks #2 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,319,669 | 21,140 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,618,835 | 21,237 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,824,566 | 21,115 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,385,830 | 18,942 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,539,216 | 19,067 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,039,126 | 19,278 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,395,313 | 19,107 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $3,609,341 | 18,277 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,054,256 | 17,807 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,112,271 | 17,091 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $2,719,103 | 17,546 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $2,640,001 | 17,711 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $2,326,921 | 17,271 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $2,631,039 | 16,509 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $2,576,225 | 15,941 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $2,144,541 | 15,979 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $2,421,612 | 15,811 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $2,530,050 | 15,607 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $2,073,244 | 15,312 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $1,678,133 | 15,557 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $1,531,678 | 13,598 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $1,419,738 | 13,119 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $1,301,336 | 12,145 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $1,072,014 | 12,239 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $1,093,234 | 11,135 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $598,396 | 7,854 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||